Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DCL000782

Drug Information
Synonyms1-alpha-Hydroxyvitamin D2; D01009; Doxcercalciferol; ZINC04641374; C08211; AKOS005146517; TSA 840; 1alpha-Hydroxyergocalciferol; LMST03010028; Doxercalciferol; Hectorol; BCI-101; (5Z,7E,22E)-9,10-Secoergosta-5,7,10(19),22-tetraene-1alpha,3beta-diol; CHEMBL1200810; Vitamin D2, 1alpha-Hydroxy-; HSCI1_000341; 1-Hydroxyergocalciferol; BRN 4716774; CID5281107; LS-144720; AC1NQY15; Hectorol (TN); (1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol; 1alpha-OH-D2; 9,10-Secoergosta-5,7,10(19),22-tetraene-1,3-diol,(1-alpha,3-beta,5Z,7E,22E); 9,10-Secoergosta-5,7,10(19),22-tetraene-1,3-diol, (1-alpha,3-beta,5Z,7E,22E)-; Doxercalciferol [INN]; 54573-75-0; Doxercalciferol (INN)    
IndicationChronic Kidney Disease; Kidney TransplantationPhase IV    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
CAS NumberCAS 54573-75-0
PubChem Compound IDCID 5281107.    
PubChem Substance IDSID 10410.    
TargetVitamin D receptorAntagonist[1]
Ref 1Emerging drugs for psoriasis. Expert Opin Emerg Drugs. 2009 Mar;14(1):145-63. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543